In 2008, Bayer had 108,600 employees and an approximate turnover of
EUR 32,918 billion. Capital expenditures amounted to EUR 1.98 billion and the R&D budget was
EUR 2.65 billion.
Bayer wants to create value through innovation, growth and an
increased profit potential. In order to do this, Bayer has positioned itself strategically and
grouped its activities into three strong and largely independent subgroups which can focus
optimally on their markets: namely
Bayer
HealthCare,
Bayer
CropScience and
Bayer
MaterialScience. They are supported by three competent service companies:
Bayer Business
Services,
Bayer Technology
Services and Currenta. The Bayer portfolio includes about 5,000 products.
In Belgium, Bayer has sites in
Ghent
(innovation centre),
Diegem
(marketing & sales organisation),
Antwerp
and
Tielt
(production units).
The primary markets for Bayer products in Belgium are: health care,
agriculture, the construction sector and the automotive industry.